Cumberland Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $10,435 | $9,085 | $9,848 | $8,497 |
Gross Profit | 8,459 | 7,762 | 6,998 | 5,771 |
EBITDA | -1,842 | 13 | 459 | -336 |
EBIT | -1,388 | -964 | -1,772 | |
Net Income | -1,903 | -1,544 | -1,085 | -1,946 |
Net Change In Cash | 10,435 | 9,085 | 9,848 | 8,497 |
Free Cash Flow | 1,877 | 516 | -902 | -2,194 |
Cash | 17,964 | 17,464 | 17,336 | 18,548 |
Basic Shares | 13,971 | 14,052 | 14,118 | 14,098 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $37,867 | $39,552 | $42,010 | $35,985 |
Gross Profit | 31,281 | 33,485 | 32,892 | 27,173 |
EBITDA | -6,432 | 153 | 332 | -857 |
EBIT | -12,475 | -5,617 | -4,995 | -5,464 |
Net Income | -6,479 | -6,279 | -5,650 | -5,597 |
Net Change In Cash | 37,867 | 39,552 | 42,010 | 35,985 |
Free Cash Flow | -678,647,000 | 5,640 | 6,379 | 5,987 |
Cash | 17,964,184,000 | 18,321 | 19,757 | 27,040 |
Basic Shares | 14,060 | 14,298 | 14,563 | 14,904 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.13 |
2024-09-30 | -$0.10 |
2024-06-30 | -$0.07 |
2024-03-31 | -$0.13 |
